home / stock / biovf / biovf short
Short Information | Swedish Orphan Biovit Ord (OTCMKTS:BIOVF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,269 |
Total Actual Volume | 8,825 |
Short Trends | |
---|---|
Cover Days | 5 |
Short Days | 15 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 163 |
Average Short Percentage | 70.19% |
Is there a BIOVF Short Squeeze or Breakout about to happen?
See the BIOVF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-28-2024 | $26.955 | $26.955 | $26.955 | $26.955 | 603 | 594 | 98.51% |
06-25-2024 | $27.5369 | $27.5369 | $27.5369 | $27.5369 | 907 | 907 | 100% |
06-13-2024 | $26.33 | $26.33 | $26.33 | $26.33 | 300 | 300 | 100% |
06-12-2024 | $26.36 | $26.36 | $26.36 | $26.36 | 440 | 10 | 2.27% |
05-03-2024 | $25.411 | $25.7557 | $25.7557 | $25.411 | 4,015 | 15 | 0.37% |
03-22-2024 | $26.948 | $26.948 | $26.948 | $26.948 | 800 | 800 | 100% |
02-29-2024 | $23.75 | $23.75 | $23.75 | $23.75 | 180 | 10 | 5.56% |
02-14-2024 | $0 | $23.32 | $0 | $0 | 127 | 75 | 59.06% |
02-08-2024 | $0 | $27 | $0 | $0 | 40 | 40 | 100% |
01-11-2024 | $0 | $27 | $0 | $0 | 1 | 1 | 100% |
01-02-2024 | $26.25 | $26.25 | $26.25 | $26.25 | 200 | 100 | 50% |
12-26-2023 | $26.2 | $26.2 | $26.2 | $26.2 | 145 | 145 | 100% |
12-21-2023 | $0 | $24.35 | $0 | $0 | 107 | 37 | 34.58% |
10-11-2023 | $0 | $20.8 | $0 | $0 | 15 | 15 | 100% |
10-02-2023 | $0 | $20.8 | $0 | $0 | 25 | 25 | 100% |
08-28-2023 | $18.35 | $18.35 | $18.35 | $18.35 | 740 | 25 | 3.38% |
08-14-2023 | $0 | $19.35 | $0 | $0 | 5 | 5 | 100% |
08-11-2023 | $0 | $19.35 | $0 | $0 | 20 | 10 | 50% |
08-01-2023 | $0 | $19.75 | $0 | $0 | 15 | 15 | 100% |
07-27-2023 | $19.75 | $19.75 | $19.75 | $19.75 | 140 | 140 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Swedish Orphan Biovit Ord Company Name:
BIOVF Stock Symbol:
OTCMKTS Market:
WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced the presentation of three abstracts that highlights data from its myelofibrosis treatment option at the American Society of Clin...
WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to emapalumab-lzsg being investigated as a pot...
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...